Vascular complications in TAVI have substantially declined over the past decade due to device evolution, improved closure techniques, and meticulous pre-procedural imaging.
Despite declines in incidence, vascular complications remain a critical safety concern in TAVI, necessitating ongoing focus on prevention, alternative access routes, and management strategies.
Absolute Event Rate: 0% vs 0%
Transcatheter aortic valve implantation (TAVI) has become the standard of care for patients with severe aortic stenosis. Despite significant procedural refinement, vascular complications (VCs) remain among the most frequent and clinically relevant adverse events associated with TAVI. These complications are closely associated with adverse clinical outcomes and continue to represent one of the most significant limiting factors for the broader expansion of TAVI indications to larger patient populations. Over the past decade, their incidence has declined substantially, largely due to device evolution, improved closure techniques, and the widespread adoption of meticulous pre-procedural imaging and planning. This narrative review provides a comprehensive overview of VCs in TAVI, focusing on contemporary incidence rates, underlying mechanisms, and patient as well as procedural-related risk factors. Additionally, the role of alternative access routes is discussed, alongside emerging technologies and future perspectives aimed at further reducing complication rates.
Nikas et al. (Tue,) reported a other. Vascular complications in TAVI have substantially declined over the past decade due to device evolution, improved closure techniques, and meticulous pre-procedural imaging.